I lead the RIA biology team in Cambridge and report directly to Tomas Mustelin Global VP of RIA based in Gaithersburg. My role and that of my team is to provide biology and pharmacology support for the molecules in our preclinical and clinical pipeline, generating in vitro and in vivo data to determine the biological activity of our antibodies, to characterise new mechanisms and pathways in our disease areas of interest and to support our clinical programmes by investigating new and alternative disease indications.